Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-027614

EVP, Research & CSO sold 2,340 shares at $48.00 ($112,320)

  • EVP, Research & CSO acquired 2,340 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-04-19 Exercise or conversion : show line 1 in the form +2,340 $1.53 $3,580 94,040 D
2021-04-19 Sale : show line 2 in the form −2,340 $48.00 $112,320 91,700 D
Open-market sales · 2,340 sh · avg $48.00 · $112,320

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-04-19 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −2,340 312,155 D
Loading xslF345X03/doc4.xml…